Product Information
55319-1-AP targets PRDM2 in WB, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | PR domain containing 2, with ZNF domain |
| Calculated Molecular Weight | 189 kDa |
| GenBank Accession Number | NM_015866 |
| Gene Symbol | PRDM2 |
| Gene ID (NCBI) | 7799 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q13029 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Publications
What published studies show
The PRDM2 Polyclonal antibody (Cat# 55319-1-AP) has 1 citation. It was used in a study published in Communications Biology (2025), which investigated how zingerone treats postmenopausal osteoporosis through p53-mediated regulation of SAT1 and GPX4 expression to increase ferroptosis sensitivity. The associated research fields include osteoporosis, ferroptosis, and p53 signaling pathway.
| Species | Application | Title |
|---|---|---|
Commun Biol Zingerone treats postmenopausal osteoporosis via increased ferroptosis sensitivity by p53-mediated regulation of SAT1 and GPX4 expression. |
